AED 📈 Aedifica - Overview
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003851681
AED: Care Homes, Nursing Homes, Healthcare Facilities, Medical Offices
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 620 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden, Ireland and Spain, worth more than '5.8 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL 20, Euronext Brussels' leading share index. Moreover, since 2023, Aedifica has been part of the BEL ESG, the index tracking companies that perform best on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600 and GPR indices. Aedifica's market capitalisation was approx. '2.6 billion as at 20 February 2024. Web URL: https://www.aedifica.eu
Additional Sources for AED Stock
AED Stock Overview
| Market Cap in USD | 2,791m |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| GiC Sub-Industry | Health Care REITs |
| IPO / Inception |
AED Stock Ratings
| Growth 5y | -37.8% |
| Fundamental | 22.3% |
| Dividend | 44.5% |
| Rel. Strength Industry | -378 |
| Analysts | - |
| Fair Price Momentum | 50.83 EUR |
| Fair Price DCF | 124.37 EUR |
AED Dividends
| Dividend Yield 12m | 6.95% |
| Yield on Cost 5y | 4.49% |
| Annual Growth 5y | -12.47% |
| Payout Consistency | 86.1% |
AED Growth Ratios
| Growth Correlation 3m | -94.4% |
| Growth Correlation 12m | 56.3% |
| Growth Correlation 5y | -69.8% |
| CAGR 5y | -7.87% |
| CAGR/Mean DD 5y | -0.27 |
| Sharpe Ratio 12m | -0.42 |
| Alpha | -25.40 |
| Beta | 0.65 |
| Volatility | 23.32% |
| Current Volume | 122.4k |
| Average Volume 20d | 69.3k |
What is the price of AED stocks?
As of December 21, 2024, the stock is trading at EUR 55.25 with a total of 122,393 shares traded.
Over the past week, the price has changed by -4.24%, over one month by -4.83%, over three months by -14.38% and over the past year by -9.01%.
As of December 21, 2024, the stock is trading at EUR 55.25 with a total of 122,393 shares traded.
Over the past week, the price has changed by -4.24%, over one month by -4.83%, over three months by -14.38% and over the past year by -9.01%.
Is Aedifica a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Aedifica is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AED as of December 2024 is 50.83. This means that AED is currently overvalued and has a potential downside of -8%.
Neither. Based on ValueRay Fundamental Analyses, Aedifica is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AED as of December 2024 is 50.83. This means that AED is currently overvalued and has a potential downside of -8%.
Is AED a buy, sell or hold?
Aedifica has no consensus analysts rating.
Aedifica has no consensus analysts rating.
What are the forecast for AED stock price target?
According to ValueRays Forecast Model, AED Aedifica will be worth about 54.9 in December 2025. The stock is currently trading at 55.25. This means that the stock has a potential downside of -0.65%.
According to ValueRays Forecast Model, AED Aedifica will be worth about 54.9 in December 2025. The stock is currently trading at 55.25. This means that the stock has a potential downside of -0.65%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 69.1 | 25.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 54.9 | -0.7% |